Jbs Pharma Chem Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2014
- Open Charges ₹ 4.38 M
About Jbs Pharma Chem
Jbs Pharma Chem Private Limited (JPCPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 April 2012 and has a history of 12 years and ten months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2014. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.38 M.
Shailesh Rane, Sanjay Nehere, Josseph Fernandesz, and One other member serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24233MH2012PTC229182
-
Company No.
229182
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Apr 2012
-
Date of AGM
30 Sep 2014
-
Date of Balance Sheet
31 Mar 2014
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Jbs Pharma Chem?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shailesh Rane
|
Director | 03-Apr-2012 | Current |
|
Sanjay Nehere
|
Director | 03-Apr-2012 | Current |
|
Josseph Fernandesz
|
Director | 03-Apr-2012 | Current |
|
Bhaskar Berad
|
Director | 03-Apr-2012 | Current |
Financial Performance of Jbs Pharma Chem.
Enhance accessibility to Jbs Pharma Chem's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jbs Pharma Chem?
Unlock access to Jbs Pharma Chem's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Styro Poly Chem Private LimitedBhaskar Berad is a mutual person
Charges (Loans)
₹4.38 M
₹0
Charges Breakdown by Lending Institutions
- Union Bank Of India : 0.44 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 May 2014 | Union Bank Of India | ₹4.38 M | Open |
How Many Employees Work at Jbs Pharma Chem?
Unlock and access historical data on people associated with Jbs Pharma Chem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jbs Pharma Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jbs Pharma Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.